Loading...
Renal cell carcinoma with central nervous system demyelination caused by nivolumab
INTRODUCTION: Central nervous system demyelination caused by immune checkpoint inhibitors is a very rare condition. CASE PRESENTATION: A 65‐year‐old man who received nivolumab for renal cell carcinoma developed abnormal behavior, such as disagreeable speech and sudden anger. Brain‐enhanced magnetic...
Na minha lista:
| Udgivet i: | IJU Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784733/ https://ncbi.nlm.nih.gov/pubmed/33426497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12234 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|